215 Results

People

  1. Patel
    Patel
  2. Nikolov
    Nikolov
  3. Freedman
    Freedman
  4. Dupont
    Dupont
  5. Pasternak
    Pasternak
  6. Hsu
    Hsu
  7. Himanen
    Himanen
  8. Chodera
    Chodera
  9. Allison
    Allison
  10. Chiosis
    Chiosis

Groups

  1. GSK Faculty (113)
  2. Sloan Kettering Institute Faculty (99)
  3. Department of Medicine (48)
  4. Sloan Kettering Institute Postdocs (39)
  5. Structural Biology Program Faculty (35)
  6. Molecular Pharmacology and Chemistry Program Faculty (34)
  7. Center for Molecular Imaging and Biotechnology (27)
  8. Solid Tumor Oncology Division (24)
  9. Center for Hematologic Malignancies (23)
  10. Tow Center for Developmental Oncology (TCDO) (23)
  1. "ligands"
Formats
  1. Journal Article (209)
  2. Review (3)
  3. Research Letter (2)
  4. Book Section (1)
Groups
  1. GSK Faculty (113)
  2. Sloan Kettering Institute Faculty (99)
  3. Department of Medicine (48)
  4. Sloan Kettering Institute Postdocs (39)
  5. Structural Biology Program Faculty (35)
  6. Molecular Pharmacology and Chemistry Program Faculty (34)

More Groups

People
  1. Dinshaw Patel (20)
  2. Dimitar Nikolov (13)
  3. Juha Himanen (12)
  4. Leonard Freedman (11)
  5. Bo Dupont (10)
  6. Gavril Pasternak (10)

More People

Years
  1. 2025 (1)
  2. 2024 (6)
  3. 2023 (11)
  4. 2022 (9)
  5. 2021 (1)
  6. 2019 (3)

More Years

Publications
  1. Journal of Biological Chemistry (18)
  2. Journal of Immunology (13)
  3. Proceedings of the National Academy of Sciences of the United States of America (10)
  4. Nature (8)
  5. Molecular and Cellular Biology (7)
  6. Science (7)

More Publications

Publishers
  1. American Chemical Society (19)
  2. American Society for Biochemistry and Molecular Biology (18)
  3. Cell Press (18)
  4. Nature Publishing Group (15)
  5. Elsevier Inc. (14)
  6. The American Association of Immunologists, Inc (13)

More Publishers

Results (215)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Differential expression of programmed cell death ligand 1 (PD-L1) and inflammatory cells in basal cell carcinoma subtypes
    Journal Article

    Gompertz-Mattar, M.; Perales, J.; Sahu, A.; Mondaca, S.; Gonzalez, S.; Uribe, P.; Navarrete-Dechent, C.
    Archives of Dermatological Research (2022)

    Fulltext@MSK | Save
  • Delta-like ligand 3–targeted radioimmunotherapy for neuroendocrine prostate cancer
    Journal Article

    Korsen, J. A.; Gutierrez, J. A.; Tully, K. M.; Carter, L. M.; Samuels, Z. V.; Khitrov, S.; Poirier, J. T.; Rudin, C. M.; Chen, Y.; Morris, M. J.; more...
    Proceedings of the National Academy of Sciences of the United States of America (2022)

    Fulltext@MSK | Save
  • Structures of β(1)-adrenergic receptor in complex with Gs and ligands of different efficacies
    Journal Article

    Su, M.; Paknejad, N.; Zhu, L.; Wang, J.; Do, H. N.; Miao, Y.; Liu, W.; Hite, R. K.; Huang, X. Y.
    Nature Communications (2022)

    Fulltext@MSK | Save
  • SAMPL7 protein-ligand challenge: A community-wide evaluation of computational methods against fragment screening and pose-prediction
    Journal Article

    Grosjean, H.; Işık, M.; Aimon, A.; Mobley, D.; Chodera, J.; von Delft, F.; Biggin, P. C.
    Journal of Computer-Aided Molecular Design (2022)

    Fulltext@MSK | Save
  • MAIT and Vδ2 unconventional T cells are supported by a diverse intestinal microbiome and correlate with favorable patient outcome after allogeneic HCT
    Journal Article

    Andrlová, H.; Miltiadous, O.; Kousa, A. I.; Dai, A.; DeWolf, S.; Violante, S.; Park, H. Y.; Janaki-Raman, S.; Gardner, R.; El Daker, S.; more...
    Science Translational Medicine (2022)

    Fulltext@MSK | Save
  • Liver immune-related adverse effects of programmed cell death 1 (PD-1) and programmed cell death ligand 1 (PD-L1) inhibitors: A propensity score matched study with competing risk analyses
    Research Letter

    Zhou, J.; Chau, Y. L. A.; Yoo, J. W.; Lee, S.; Ng, K.; Dee, E. C.; Liu, T.; Wai, A. K. C.; Zhang, Q.; Tse, G.
    Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Radioimmunotherapy targeting Delta-like ligand 3 in small cell lung cancer exhibits antitumor efficacy with low toxicity
    Journal Article

    Tully, K. M.; Tendler, S.; Carter, L. M.; Sharma, S. K.; Samuels, Z. V.; Mandleywala, K.; Korsen, J. A.; Reyes, A. M. D.; Piersigilli, A.; Travis, W. D.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Structure–function analysis of oncogenic EGFR Kinase Domain Duplication reveals insights into activation and a potential approach for therapeutic targeting
    Journal Article

    Du, Z.; Brown, B. P.; Kim, S.; Ferguson, D.; Pavlick, D. C.; Jayakumaran, G.; Benayed, R.; Gallant, J. N.; Zhang, Y. K.; Yan, Y.; more...
    Nature Communications (2021)

    Fulltext@MSK | Save
  • NECA derivatives exploit the paralog-specific properties of the site 3 side pocket of Grp94, the endoplasmic reticulum Hsp90
    Journal Article

    Huck, J. D.; Que, N. L. S.; Immormino, R. M.; Shrestha, L.; Taldone, T.; Chiosis, G.; Gewirth, D. T.
    Journal of Biological Chemistry (2019)

    Fulltext@MSK | Save
  • Integrating ligand-receptor interactions and in vitro evolution for streamlined discovery of artificial nucleic acid ligands
    Journal Article

    Zumrut, H. E.; Batool, S.; Argyropoulos, K. V.; Williams, N.; Azad, R.; Mallikaratchy, P. R.
    Molecular Therapy - Nucleic Acids (2019)

    Fulltext@MSK | Save